Is Bacil Pharma a good stock to invest in?

Bacil Pharma can be analyzed on the following key metrics - TTM P/E: 62.49 Sector P/E: 22.66 Dividend Yield: 0% D/E ratio: -

Bacil Pharma Share Price

Sector: Biotechnology & Drugs

Powered by

37.68 0.00 (0.00%)

1D
5D
1M
3M
6M
1Y
5Y
MAX

Price Range

Today’s Low 0.00

Today’s High 0.00

52 Week Low 14.85

52 Week High 62.56

Key Metrics

Market Cap (In Cr) 22.19
Beta -0.76
Div. Yield (%) 0
P/B 2.07
TTM P/E 62.49
Peg Ratio -
Sector P/E 22.66
D/E 0
Open Price 0
Prev Close 37.68

View All Metrics

Bacil Pharma Analysis

Price Analysis

1 Week

-4.56%
3 Months

-2.46%
6 Month

-39.77%
YTD

-30.66%
1 Year

56.93%

Risk Meter

45% Low risk
45% Moderate risk
45% Balanced Risk
45% High risk
45% Extreme risk

Bacil Pharma Financials

INCOME
BALANCE SHEET
Cashflow

DATE

Annual

Quarterly

Period
2025

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.14

Depreciation/ Amortization
0

Other Operating Expenses Total
0.11

Total Operating Expense
0.25

Operating Income
-0.25

Net Income Before Taxes
0.41

Net Income
0.4

Diluted Normalized EPS
0.64

Period
2024

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.1

Depreciation/ Amortization
0

Other Operating Expenses Total
0.09

Total Operating Expense
0.19

Operating Income
-0.19

Net Income Before Taxes
-0.06

Net Income
-0.06

Diluted Normalized EPS
-0.1

Period
2023

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.09

Depreciation/ Amortization
0

Other Operating Expenses Total
0.09

Total Operating Expense
0.18

Operating Income
-0.18

Net Income Before Taxes
-0.1

Net Income
-0.1

Diluted Normalized EPS
-0.17

Period
2022

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.06

Depreciation/ Amortization
0

Other Operating Expenses Total
0.1

Total Operating Expense
0.16

Operating Income
-0.16

Net Income Before Taxes
-3.86

Net Income
-3.86

Diluted Normalized EPS
-2.47

Period
2021

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.05

Depreciation/ Amortization
0

Other Operating Expenses Total
0.11

Total Operating Expense
0.17

Operating Income
-0.17

Net Income Before Taxes
-0.24

Net Income
-0.24

Diluted Normalized EPS
-0.41

Period
2020

Total Revenue
0

Selling/ General/ Admin Expenses Total
0.09

Depreciation/ Amortization
0.01

Other Operating Expenses Total
0.1

Total Operating Expense
0.2

Operating Income
-0.2

Net Income Before Taxes
-0.32

Net Income
-0.32

Diluted Normalized EPS
-0.54

View detailed financials

Forecast

Income Sheet (In Cr) Net Income Vs Revenue

Returns Metrics (In Cr) ROA Vs ROE

Forecast

Balance Sheet Asset vs Liability

Forecast

Cash Flow Operating vs Investing

Bacil Pharma Technical

Moving Average SMA

5 Day40.79
10 Day40.71
20 Day41.41

50 Day41.37
100 Day45.75
300 Day40.72

Bacil Pharma Peers

Price
Ratio

Name
Latest Price
Change
% Change
52W High
52W Low
Mkt. Cap

Phaarmasia
32.3
-1.7
-5
64.75
23.6
22.05

Zenith Health Care
4.5
0.38
9.22
6.87
3.82
24.18

Bacil Pharma
37.68
0
0
62.56
14.85
22.19

Ishita Drugs And Industries
75.97
2.87
3.93
104.75
62.2
22.72

Fone4 Communications (india)
7.42
-0.38
-4.87
19.25
3.78
12.65

Bacil Pharma Shareholding

Shareholding Pattern

Shareholding Trend

Shareholding(%) v/s Date

View All

Corporate Actions

Board Meeting
AGM
Dividends
Bonus
Split
Rights

Meeting Date
Purpose

26-May-25
Audited Results

21-Jan-25
Quarterly Results

23-Oct-24
Quarterly Results

15-Oct-24
Others

27-Sept-24
Increase in Authorised Capital

14-Aug-24
Quarterly Results

21-May-24
Audited Results

13-Feb-24
Quarterly Results

10-Nov-23
Quarterly Results

14-Aug-23
Quarterly Results

Meeting Date
Announced on
Purpose

14-Nov-24
23-Oct-24
EGM

27-Sept-24
09-Sept-24
AGM

16-Sept-23
24-Aug-23
AGM

View All

Company Profile

ABOUT Bacil Pharma

Industry Biotechnology & Drugs
ISIN INE711D01018
BSE Code 524516

Bacil Pharma Limited is an India-based pharmaceutical company, which is engaged in the business of manufacturing of pharmaceuticals, medicinal chemicals and botanical products. The Company operates as a manufacturer, exporter, supplier and retailer of a range of anti-anxiety medicine, antihistamines, chemical compound, drugs, and herbal tablets and capsules.

MANAGEMENT

Jayesh Patil Chief Financial Officer
Bhavana Tak Compliance Officer, Company Secretary
Ganpat Salekar Manager

BACIL PHARMA SUMMARY

Bacil Pharma is trading 0.00% lower at Rs 37.68 as compared to its last closing price. Bacil Pharma has been trading in the price range of 0.00 & 0.00. Bacil Pharma has given -30.66% in this year & -4.56% in the last 5 days.

Bacil Pharma has TTM P/E ratio 62.49 as compared to the sector P/E of 22.66.

The company posted a net profit of 0.02 Crores in its last quarter.

Listed peers of Bacil Pharma include Phaarmasia (-5%), Zenith Health Care (9.22%), Bacil Pharma (0%) etc.

Bacil Pharma has a 0.2% promoter holding & 99.8% public holding.

FAQs about Bacil Pharma

Bacil Pharma is trading at 37.68 as on 16 Jun, 2025 7:36:53 AM. This is 0.00% lower as compared to its previous closing price of 37.68

The market capitalization of Bacil Pharma is 22.19 Cr as on 16 Jun, 2025 7:36:53 AM.

The 52 wk high for Bacil Pharma is 62.56 whereas the 52 wk low is 14.85

Bacil Pharma can be analyzed on the following key metrics -

TTM P/E: 62.49
Sector P/E: 22.66
Dividend Yield: 0%
D/E ratio: -

Bacil Pharma reported a net profit of 0.4 Cr in 2025.

Bacil Pharma Quick Links

Equity Quick Links

Top Gainers | Top Losers | Indian Indices | BSE Active Stocks | NSE Active Stocks

Bacil Pharma Share Price

Price Range

Key Metrics

Bacil Pharma Analysis

Bacil Pharma Financials

Forecast

Forecast

Forecast

Bacil Pharma Technical

Bacil Pharma Peers

Bacil Pharma Shareholding

Shareholding Pattern

Shareholding Trend

Corporate Actions

Company Profile

ABOUT Bacil Pharma

MANAGEMENT

BACIL PHARMA SUMMARY

FAQs about Bacil Pharma

Wait for it…

Wait for it…

Congratulations!

Subscribe to continue